Medicare Advantage Plan Changes for 2027: Key Updates and Impacts

The Centers for Medicare & Medicaid Services (CMS) has introduced policy changes to streamline Medicare Advantage plan selections, improve prescription drug coverage, and refine quality ratings. Approximately 65 million Americans are currently enrolled in Medicare, impacted by these significant regulatory updates.

These changes align with a proposed decision to maintain Medicare Advantage base payments at current levels for 2027, while enhancing risk-adjustment measures. Insurers have raised concerns about possible reductions in benefits if funding fails to keep pace with rising medical expenses, highlighting the crucial balance of medical underwriting and effective payout management.

Key adjustments focus on simplifying Medicare plans and strengthening financial protections for beneficiaries. Under the Contract Year 2027 rules, applicable to both Medicare Advantage and prescription drug plans, beneficiaries will be better equipped to make informed decisions, manage costs, and secure reliable coverage.

One significant update includes an overhaul of the Star Ratings system, which now emphasizes clinical quality, patient outcomes, and overall patient experience for Medicare Advantage and Part D plans. This update aims to improve behavioral health care by introducing measures like depression screening while maintaining essential metrics like diabetes eye exams to ward off severe health issues.

CMS also decided against adding a proposed health equity incentive but continues to reward plans demonstrating consistent performance across diverse patient demographics. Administrative simplifications will reduce unnecessary regulatory compliance, particularly affecting enrollment information and documentation for providers and carriers.

The rule fortifies prescription drug protections by enacting changes from the Inflation Reduction Act, such as eliminating the coverage gap phase, lowering the annual out-of-pocket cap, and abolishing cost-sharing at the catastrophic coverage level. These changes aim to reduce the financial burden on individuals relying on prescription medications.

Further improvements in Medicare Advantage plans include stricter oversight of supplemental benefits to enhance transparency and prevent fraud. CMS Administrator Dr. Mehmet Oz underscored these regulations' goals to simplify Medicare access, focus on patient outcomes, and curb excessive costs. Meanwhile, Chris Klomp, Director of the Medicare Center, highlighted the move towards a quality-driven, patient-centered healthcare system. The open enrollment for 2027 Medicare Advantage plans begins in October, aligning with the most recent payment rates and rating methodologies.